Peripheral Neuropathy Trial, Recruiting (NCT06754995)

Peripheral Neuropathy Trial, Recruiting NCT06754995 Sponsor: University of Debrecen Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT06754995 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People rated as ASA physical status class 1, 2, or 3, meaning they are in generally good to moderate health (confirm with trial site)
People with a body mass index (BMI) between 18.5 and 25, which is considered a normal, healthy weight range
People who can lie flat on their back during the procedure with at least one arm reachable by medical staff

Who may not be able to join:

People who have conditions that affect how muscles and nerves work together, such as muscle diseases or severe liver or kidney failure
People who are taking medications known to affect muscle and nerve function, such as magnesium or aminoglycoside antibiotics
People who are pregnant (women of childbearing age will be given a pregnancy test to check)
People who are currently breastfeeding
People who require emergency or urgent surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Béla Fülesdi, MD PhD DSci, University of Debrecen

Phone: +36302390132

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06754995

Sponsor: University of Debrecen

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: +36302390132

More information: https://clinicaltrials.gov/study/NCT06754995

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People rated as ASA physical status class 1, 2, or 3, meaning they are in generally good to moderate health (confirm with trial site)
People with a body mass index (BMI) between 18.5 and 25, which is considered a normal, healthy weight range
People who can lie flat on their back during the procedure with at least one arm reachable by medical staff

Who may not be able to join:

People who have conditions that affect how muscles and nerves work together, such as muscle diseases or severe liver or kidney failure
People who are taking medications known to affect muscle and nerve function, such as magnesium or aminoglycoside antibiotics
People who are pregnant (women of childbearing age will be given a pregnancy test to check)
People who are currently breastfeeding
People who require emergency or urgent surgery

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Debrecen

Registry

ClinicalTrials.gov

Start date

6 January 2025

Est. completion

31 December 2026

Where this trial is recruiting

🇭🇺 Hungary

Primary endpoints

100 Hz tetanic fade response of abductor digiti minimi muscle to ulnar nerve stimulation in patients with normal and abnormal ENG

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov